Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Lyophilization Equipment and Services
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Tray Lyophilizers, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$5.0 Billion by the ... Read More
-
Diabetes Drugs
... CAGR of 9.3% over the analysis period 2024-2030. Oral Drugs, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$163.4 Billion by the end of the analysis ... Read More
-
Microencapsulation
... 12.4% over the analysis period 2024-2030. Spray, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$10.2 Billion by the end of the analysis period. Growth in ... Read More
-
Proanthocyanidins
... 6.2% over the analysis period 2024-2030. Cranberry, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$177.2 Million by the end of the analysis period. Growth in ... Read More
-
Campesterol
... 8.5% over the analysis period 2024-2030. Food Ingredients, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$143.1 Million by the end of the analysis period. Growth ... Read More
-
Sustained Release Excipients
... at a CAGR of 6.0% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Urothelial Cancer Drugs
... at a CAGR of 20.7% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$13.3 Billion by the end of the ... Read More
-
Anti-Counterfeit Packaging
... CAGR of 9.2% over the analysis period 2024-2030. Mass Encoding, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$109.6 Billion by the end of the analysis ... Read More
-
Pharmaceutical Packaging Equipment
... at a CAGR of 8.6% over the analysis period 2024-2030. Primary Packaging Equipment, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$16.7 Billion by the end ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 Billion ... Read More
-
Hyperlipidemia Drugs
... CAGR of 0.9% over the analysis period 2024-2030. Statins, one of the segments analyzed in the report, is expected to record a -7.3% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
India Pharmaceuticals and Medicine - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals and Medicine (India) report will tell you the ... Read More
-
Belgium Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Belgium) report will tell you the companies that have a declining financial ... Read More
-
Healthcare Preparations (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Healthcare Preparations (UK) report will tell you the companies that have ... Read More
-
Medical Logistics (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Medical Logistics (UK) report will tell you the companies that have ... Read More
-
Pharmaceutical Manufacturers & Distributors (UK) - Industry Report
... failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceutical Manufacturers & Distributors (UK) report will ... Read More
-
Pharmaceutical Wholesalers (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceutical Wholesalers (UK) report will tell you the companies that have ... Read More
-
Oral Solid Dosage Contract Manufacturing Global Market Report 2025
... solid dosage contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Oral Solid Dosage Pharmaceutical Formulation Global Market Report 2025
... solid dosage pharmaceutical formulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Cannabis Production in Canada - Industry Market Research Report
... in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed recreational market, cannabis growers have grown significantly, but revenue ... Read More
-
Contract Research Outsourcing
... at a CAGR of 7.9% over the analysis period 2024-2030. Clinical, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$61.2 Billion by the end of the ... Read More
-
Antibiotics
... 3.1% over the analysis period 2024-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in ... Read More
-
Ampoules Packaging
... CAGR of 6.2% over the analysis period 2024-2030. Glass Packaging, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$5.6 Billion by the end of the analysis ... Read More
-
Angina Pectoris Drugs
... at a CAGR of 4.5% over the analysis period 2024-2030. Beta Blockers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Bulk Paclitaxel
... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More
Research Assistance
